Skip to main content
Atrás
Watch Compare

Coya Therapeutics, Inc.

Calidad de datos: 100%
COYA
Nasdaq Manufacturing Chemicals
$4.48
▲ $0.37 (9.00%)
Cap. Mercado: 105.09 M
Precio
$4.48
Cap. Mercado
105.09 M
Rango del Día
$4.14 — $4.58
Rango de 52 Semanas
$3.71 — $7.75
Volumen
286,698
Apertura $4.14
Promedio 50D / 200D
$4.60
2.56% below
Promedio 50D / 200D
$5.61
20.13% below

Quick Summary

Puntos Clave

Negative free cash flow of -10.74 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)123.57%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-76.36%
Below sector avg (-53.41%)
ROIC-62.16%
Net Margin-267.14%
Op. Margin-283.87%

Seguridad

Debt / Equity
N/A
Current Ratio8.73
Interest CoverageN/A

Valoración

PE (TTM)
-4.95
Below sector avg (-1.48)
P/B Ratio3.85
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -5.0 -1.5
P/B 3.9 1.6
ROE % -76.4 -53.4
Net Margin % -267.1 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 123.57% Revenue Growth (3Y) 15.06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7.95 M Net Income (TTM) -21.23 M
ROE -76.36% ROA -64.82%
Gross Margin N/A Operating Margin -283.87%
Net Margin -267.14% Free Cash Flow (TTM) -10.74 M
ROIC -62.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.73
Interest Coverage N/A Asset Turnover 0.24
Working Capital 28.36 M Tangible Book Value 27.28 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.95 Forward P/E N/A
P/B Ratio 3.85 P/S Ratio 13.23
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.22%
Market Cap 105.09 M Enterprise Value 76.96 M
Per Share
EPS (Diluted TTM) -1.27 Revenue / Share 0.34
FCF / Share -0.46 OCF / Share -0.46
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 50.59%
SBC-Adj. FCF -14.70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 7.95 M 3.55 M 6.00 M —
Net Income -21.23 M -14.88 M -7.99 M -12.24 M
EPS (Diluted) -1.27 -0.98 -0.79 -4.73
Gross Profit — — — —
Operating Income -22.56 M -17.25 M -7.90 M -9.81 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — — —
Income Tax 3,089.0 -720,287.0 723,852.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 49.95 M 44.35 M 41.26 M 8.40 M
Total Liabilities 6.92 M 4.77 M 5.63 M 16.79 M
Shareholders' Equity 43.03 M 39.58 M 35.64 M -8.39 M
Total Debt — — — —
Cash & Equivalents 46.82 M 38.34 M 32.63 M 5.93 M
Current Assets 49.94 M 44.31 M 41.20 M 7.18 M
Current Liabilities 5.87 M 3.82 M 5.05 M 3.82 M